Category Archives: As I See It

Pharma’s real problems with digital marketing

KEY TAKEAWAY: According to Sloan Management Review “employees and executives are highly inclined to jump ship if they feel they don’t have opportunities to develop digital skills”.  While there are some digital pioneers trying to push the boundaries of digital marketing the industry continues to bleed talent. Continue reading

Medical Device companies need more oversight, not less

KEY TAKEAWAY: Via the NY Times “makers of cardiac defibrillators, insulin pumps, breast implants and other medical devices might be able to delay reporting dangerous malfunctions to the Food and Drug Administration under an agreement heading for a vote in Congress”.  This is not the way to ensure medical device companies stay compliant. Continue reading

Cancer DTC: confusing or helpful?

KEY TAKEAWAY:According to PBS.org surprisingly, huge numbers of cancer patients lack basic information, such as how long they can expect to live, whether their condition is curable or why they’re being prescribed chemotherapy or radiation, said Dr. Rab Razzak, director of outpatient palliative medicine at Johns Hopkins Medicine in Baltimore.  The result: People with advanced cancer don’t know enough about their disease to make informed decisions about treatment or how they want to spend their remaining time.  But is the new DTC for Oncology products, adding to the confusion? Continue reading